Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2020				51,679,516
Beginning balance at Dec. 31, 2020		$ 624,428		$ 523	$ 522,911	$ 77,652		$ 29,403	$ (6,061)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		12,035				12,035
Other comprehensive loss		(6,857)						(6,857)
Issuance of shares from equity-based awards (in shares)				87,650
Issuance of shares from equity-based awards		(404)			(404)
Open market common share repurchases		(1,052)							(1,052)
Open market common share repurchases (in shares)				(88,497)
Employee receivables from sale of stock		35				35
Stock-based compensation		649			649
Ending balance (in shares) at Mar. 31, 2021				51,678,669
Ending balance at Mar. 31, 2021		628,834		$ 523	523,156	89,722		22,546	7,113
Beginning balance (in shares) at Dec. 31, 2021				50,450,045
Beginning balance at Dec. 31, 2021		667,573		$ 526	526,806	147,099		21,489	(28,347)
Beginning balance (ASU 2016-13 [Member]) at Dec. 31, 2021	[1]		$ (2,610)				$ (2,610)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		16,828				16,828
Other comprehensive loss		(42,501)						(42,501)
Issuance of shares from equity-based awards (in shares)				303,040
Issuance of shares from equity-based awards		(617)		$ 3	(620)
Open market common share repurchases		(16,762)							(16,762)
Open market common share repurchases (in shares)				(1,058,332)
Employee receivables from sale of stock		6				6
Stock-based compensation		1,115			1,115
Exercise of warrants (in shares)				33,500
Exercise of warrants		167			167
Ending balance (in shares) at Mar. 31, 2022				49,728,253
Ending balance at Mar. 31, 2022		$ 623,199		$ 529	$ 527,468	$ 161,323		$ (21,012)	$ (45,109)

[1] (a)   Includes the impact of implementing Accounting Standards Update (“ASU”)   2016-13, Financial Instruments - Credit Losses (Accounting Standard Codification   (“ASC”) 326): Measurement of Credit Losses on Financial Instruments.   See “Note 1: Nature of Operations and Summary of Significant Accounting Policies” in   the Notes to Condensed Consolidated Financial Statements (unaudited) for more information on the   Company’s adoption of this guidance   and the impact to the Company’s   results of operations.